FDA Inspection 1234037 — PAI Holdings LLC

PAI Holdings LLC — FEI 1017687

The FDA completed an inspection of PAI Holdings LLC on January 28, 2025 in Greenville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Greenville, SC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)